Skip to main content

Month: August 2022

World Insurance Associates Increases Rhode Island Presence with the Acquisition of Howard Russell Insurance

Iselin, NJ, Aug. 19, 2022 (GLOBE NEWSWIRE) — World Insurance Associates LLC (“WIA”), a Top 50 Insurance Brokerage, announced today that it acquired Howard Russell Insurance (“Howard Russell”)  of  East Greenwich, RI on June 1, 2022. Terms of the transaction were not disclosed. Howard Russell Insurance was founded in 1956 by Howard E. Russell, Jr., and his wife, Bess.  Today the company is owned and operated by their daughters, Sally Russell and Heidi Russell Duggan. Howard Russell is a full service, independent insurance agency serving the needs of clients throughout Rhode Island and southern New England.  “At Howard Russell we are committed to excellence,” says Sally Russell, Owner, Howard Russell Insurance. “Since our founding in 1956, we have been working hard to ensure our clients receive the best possible insurance services.”...

Continue reading

STEALTHGAS INC. Announces the Date for the Release of the Second Quarter and Six Months 2022 Financial and Operating Results, Conference Call and Webcast

ATHENS, Greece, Aug. 19, 2022 (GLOBE NEWSWIRE) — STEALTHGAS INC. (NASDAQ: GASS) (the “Company”), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today that it will release its second quarter operating and financial results for the period ended June 30, 2022 before the market opens in New York on August 24, 2022. On August 24, 2022 at 11:00 am ET, the company’s management will host a conference call to discuss the results and the company’s operations and outlook. Conference Call details: Beginning this quarter, conference call participants should pre-register using the below link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. Online Registration: https://register.vevent.com/register/BIa9f97f598485467ab13a03607f4a77f9 Slides...

Continue reading

CSC and Intertrust have obtained Regulatory Clearance in Singapore

JOINT PRESS RELEASE This is a joint press release by Intertrust N.V. (“Intertrust” or the “Company”) and CSC (Netherlands) Holdings B.V. (“CSC” or the “Offeror”) in connection with the recommended public offer (the “Offer”) by the Offeror for all the issued and outstanding ordinary shares in the capital of Intertrust. This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in Intertrust. Any offer will be made only by means of the offer memorandum (the “Offer Memorandum”) approved by the Dutch Authority for Financial Markets (Stichting Autoriteit Financiële Markten, the “AFM”) which was published on 31 March 2022, and subject to the restrictions set forth therein. With reference to the joint...

Continue reading

Prosafe SE: Grant of share options

As part of the Company’s long-term incentive program approved by the General Meeting on 11 May 2022, the Board of Directors has granted the new CFO, Reese McNeel, who joined the company on 01 August 2022, 100,000 options. The options earlier granted to the previous DCEO & CFO, Stig H. Christiansen, were cancelled in connection with his resignation. Following the grant, Reese McNeel has 100,000 share options and 0 shares in Prosafe SE. The strike price is set as the closing price on 19 August 2022 and the options will vest with 1/3 after 24 months, 1/3 after 36 months and 1/3 after 48 months. Any options not exercised at the date 60 months after 19 August 2022 will be cancelled. Jesper K. Andresen, CEO and Ryan Stewart, COO were on 10 February 2022 granted 150,000 and 100,000 share options, respectively, at a strike price of NOK 83.00...

Continue reading

Mydecine Innovations Group Announces Private Placement; Interim Changes to Management and Board of Directors

DENVER, Aug. 19, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, is pleased to announce that it has entered into a Common Share Subscription Agreement (the “Subscription Agreement”) with a third-party investor in the Company (the “Subscriber”) on August 15th, 2022. Pursuant to the Subscription Agreement, the Subscriber subscribed for, and the Company issued, 326,666 common shares in the capital of the Company at a subscription price of $0.75 per common share for aggregate gross proceeds to the Company of $244,999.50. The funds raised through this private placement will be used...

Continue reading

PHI Group, Inc. Acquires Majority Interest in Tin Thanh Group

New York, Aug. 19, 2022 (GLOBE NEWSWIRE) — PHI Group, Inc. (n/k/a Philux Global Group Inc., www.phiglobal.com, PHIL), a diversified holding company currently sponsoring PHILUX Global Funds (a group of Luxembourg bank funds), developing the Asia Diamond Exchange project (“ADE”) in Vietnam, engaging in mergers and acquisitions and investing in special situations (www.co2-1-0.io), is pleased to announce that the Company has signed an agreement to acquire 51% of Tin Thanh Group (TTG) (https://tinthanhgroup.vn/en/) for cash. According to the agreement, PHI Group will purchase 22,032,000 shares of Ordinary Stock from the majority shareholder of Tin Thanh Group, which is equivalent to 51% all TTG’s issued and outstanding ordinary stock, for a total sixty million U.S. dollars. The closing of this transaction is scheduled to occur by October...

Continue reading

Landsnet’s interim financial statement for the January-June, 2022

Landsnet’s interim financial statement for the January-June, 2022 period was published today.  Guðlaug Sigurðardóttir, CFO at Landsnet, says operations are stable and on schedule despite challenges in the supply chain.  “We are focussed on ensuring cost-effective and stable operations, essential to a key infrastructure company like Landsnet and its customers. We are proud of our performance and ability to deliver, despite the current upheaval in world markets and temporary energy shortages in Iceland during the spring months. Energy shortages caused a temporary increase in the tariff for transmission losses. Company operations were successful. Profit for the period is above expectations and can largely be attributed to increased income due to transmission losses. Landsnet expects to achieve a balance between income and expenses...

Continue reading

Correction: Kvika banki hf.: Financial Results for the First Six Months of 2022 and Earnings Outlook for the Next Four Quarters

In note no. 4, on page no. 13 in the Group’s consolidated interim financial statements 30.06.2022 that were published on 18 August 2022, a table containing the performance of Group’s business segments for the first six months of the year is displayed. By mistake the figures for the net financial income for the business segments Asset Management and Commercial Banking were not correct. The correct figures are ISK 18,993 thousand for Asset Management and ISK 479,886 thousand for Commercial Banking. The correction has a corresponding effect on the net operating income and profit before tax for the business segments. The figures in the investor presentation were correct. The aforementioned correction does not have an effect on the Group’s income statement or its statement of financial position. Attached is a corrected version of the Group’s...

Continue reading

Vyant Bio Announces Rescheduled Investor Conference Call and Webcast for the Second Quarter and First Half of 2022

CHERRY HILL, N.J., Aug. 19, 2022 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s proprietary central nervous system (“CNS”) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Today, Vyant Bio announced that it will release its financial results for the second quarter and first half ended June 30, 2022, on Monday, August 22, 2022. Vyant Bio will host an investor conference call and webcast on Monday, August 22, 2022 at 4:30 pm ET. Jay Roberts, Chief Executive Officer, Andy LaFrence, Chief Financial Officer, and Robert Fremeau, PhD, Chief Scientific Officer, of Vyant Bio will provide an update...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.